Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 3,967 recruiting studies in this area right now.
By phase
- Not applicable2,544
- Phase 2357
- Phase 4303
- Phase 1288
- Phase 3283
- Phase 1/Phase 2133
- Phase 2/Phase 359
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris69
- University of California, San Francisco39
- Johns Hopkins University30
- National Cancer Institute (NCI)28
- Hospices Civils de Lyon27
- Columbia University24
- University of Oxford23
- University of Washington23
- University of Alabama at Birmingham22
Where studies are running
- California234
- Maryland142
- Alabama92
- New York73
- Florida72
- Texas62
- Massachusetts57
- Arizona48
- Pennsylvania43
- Illinois41
Recruiting studies3,967 total
- NCT07324954RecruitingPhase 1
Methylene blue for knee replacement surgery
This study tests if using a blue dye called methylene blue during knee replacement surgery can help doctors see and clean out infections better. It may help people having a first-time knee replacement or those with an infected knee replacement.
Miami, FloridaAges 18 years+ - NCT07329166Recruiting
Reducing HIV treatment interruptions in Malawi
This study tests a program to help people in Malawi stay on their HIV treatment even when they travel or move around. Researchers want to know if extra support can prevent gaps in care.
LilongweAges 15 years+ - NCT07329686RecruitingPhase 1/Phase 2
Anti-VEGF Injection for Herpes-Related Corneal Blood Vessels
This study tests whether injecting an anti-VEGF medication directly into the clear part of your eye (cornea) can safely reduce abnormal blood vessels caused by a herpes virus eye infection. If you have HSV keratitis with new vessel growth and haven't had prior anti-VEGF treatment or corneal surgery, this trial may be an option for you.
Hangzhou, ZhejiangAges 18 years+ - NCT03559569Recruiting
Study blood changes in people with circulatory shock
This study looks at how blood vessel and white blood cell aging changes during circulatory shock. Your participation may help doctors better understand what’s happening in the body during shock.
StrasbourgAges 18 years+ - NCT06046079Recruiting
HIV Prevention Service Use Study in Washington DC
This study looks at how people in the Washington, DC area use HIV prevention services. It focuses on those who are HIV-negative and either new to PrEP, taking daily PrEP pills, or getting long-acting injectable PrEP.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06856967Recruiting
Nirsevimab for RSV in infants under 1 year
This study looks at whether the drug nirsevimab can reduce hospitalizations caused by RSV (a common respiratory virus) in babies under 1 year old. If your baby has a lung infection like bronchiolitis or pneumonia, this trial may help understand how well the medicine works.
Arezzo, ArezzoAges Up to 1 year - NCT06859814Recruiting
Infection control for catheterized patients
This trial tests if a special infection control program can reduce infections in patients with urinary catheters in the hospital. It may help prevent catheter-related infections during your stay.
Sohag, Sohag GovernorateAges 18 years+ - NCT06866535Recruiting
Vascular infection study for patients 18 and older
This trial is studying patients with infections in blood vessels, whether natural or from a graft, to better understand and treat them.
BordeauxAges 18 years+ - NCT05876598Recruiting
Predict bloodstream infection risk using a computer model
This study builds and tests a computer (machine-learning) model to predict bloodstream infections based on what happens in the first days of care. It may help doctors start the right antibiotic faster for patients who truly have an infection.
RomeAges 18 years+ - NCT06870435Recruiting
Screening for nasopharyngeal cancer with blood tests
This study compares three different blood tests to see which works best for spotting nasopharyngeal cancer early in people at higher risk. If you live in certain areas of China, you may be able to join.
Zhuhai, GuangdongAges 30–69 - NCT07319299Enrolling by invitation
Liver cancer screening study for people with chronic liver disease
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
Bangkoknoi, BangkokAges 18 years+ - NCT07316192Recruiting
Comparing two wound dressings for hidradenitis suppurativa surgery
This study compares two wound dressings used after surgery for hidradenitis suppurativa (HS) to see which one helps wounds heal better. It may help if you need a wide surgical excision for HS and can attend follow-up visits.
Newark, New JerseyAges 18 years+ - NCT07316127RecruitingPhase 2
Blood filtering for autoimmune long COVID
This trial tests if filtering certain antibodies from the blood can help people with long COVID who experience post-exertional malaise (PEM) and reduced function. It aims to see if this treatment reduces symptoms and improves daily life.
AmsterdamAges 18–65 - NCT07321704Recruiting
Irrisept vs. Saline for Pilonidal Flap Surgery
This study compares two types of wound cleaning solutions used during surgery for pilonidal disease: an antiseptic called Irrisept (0.05% chlorhexidine gluconate) versus normal saline. The goal is to see if Irrisept helps prevent infection and improve healing after a flap-based closure procedure.
Los Angeles, CaliforniaAges 18 years+ - NCT07317687Recruiting
Rapid HIV, Hep C, and Syphilis Testing in Street Medicine
This trial offers free rapid testing for HIV, hepatitis C, and syphilis during street medicine visits. It helps find infections early so you can get connected to care.
Harpers Ferry, West VirginiaAges 18 years+ - NCT07322146Enrolling by invitationPhase 4
Shorter antibiotics for children with common infections
This study tests whether shorter courses of antibiotics are as effective as longer ones for children hospitalized with pneumonia, skin infections, or urinary tract infections. It may help children get back to normal faster and reduce side effects.
Birmingham, AlabamaAges 2 months–17 years - NCT07320638Enrolling by invitation
TRIM25 study in people with sepsis
This trial looks at a protein called TRIM25 in patients with sepsis (a serious infection). It may help doctors understand the condition better.
ShanghaiAges 18–70 - NCT07321314Recruiting
RSV infection study in Hong Kong adults
This study looks at how common RSV (a virus that can cause coughing and breathing problems) is in adults with a recent respiratory infection. If you have a cough or other cold-like symptoms and are 18 or older, you might be able to help by giving a sputum and saliva sample.
Hong KongAges 18 years+ - NCT07322302Recruiting
Comparing two approaches for repeat eyelash surgery
This study compares two ways of doing repeat surgery for trichiasis (eyelashes turning inward) on the upper eyelid. The surgeries will be done by specially trained eye care workers, and the goal is to see which approach works better.
Chapel Hill, North CarolinaAges 18 years+ - NCT07317011Recruiting
Active referral for hepatitis B patients
This trial aims to connect adults with chronic hepatitis B to proper care. It tests an active referral program for patients hospitalized in specific departments in Bergamo, Italy, or attending certain clinics, to see if it improves follow-up and treatment.
BergamoAges 18–100 - NCT07317167Enrolling by invitation
Water safety plan study in Ghana
This trial is testing a water safety plan to improve drinking water quality in Ghana. It may help people who get their water from certain private water suppliers.
AccraAges 18 years+ - NCT07317154RecruitingPhase 1
Dendritic cell vaccine for HPV type 6 recurrent respiratory papillomatosis
This Phase 1 trial is testing a vaccine made from your own immune cells (dendritic cells) that may help your body fight the virus causing recurrent papillomas in your voice box. It is for people whose papillomas are caused by HPV type 6, who have had at least one recurrence in the past year.
Scottsdale, ArizonaAges 18 years+ - NCT05791396RecruitingPhase 1/Phase 2
Fecal microbiome therapy to clear hard-to-treat gut germs
This trial looks at a treatment made from stool donors (called fecal microbiome therapy) to help remove carbapenem-resistant gut bacteria in the body. It’s mainly for adults who recently tested positive for these bacteria on a rectal swab, and it checks whether the therapy can help eradicate the germs.
RomaAges 18–85 - NCT06191302Recruiting
Long COVID study in Denmark
This study follows people who were hospitalized for COVID-19 to learn more about long-term health effects (post-COVID conditions). It uses blood samples already collected during their hospital stay.
HvidovreAges 18 years+
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 3,967 recruiting infectious disease studies from the U.S. registry right now, out of 6,571 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.